nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyldopa—Distention—Metformin—polycystic ovary syndrome	0.055	0.216	CcSEcCtD
Methyldopa—DDC—embryo—polycystic ovary syndrome	0.0214	0.112	CbGeAlD
Methyldopa—Metyrosine—TH—polycystic ovary syndrome	0.0153	0.257	CrCbGaD
Methyldopa—DDC—adrenal gland—polycystic ovary syndrome	0.0127	0.0664	CbGeAlD
Methyldopa—SLC15A1—endometrium—polycystic ovary syndrome	0.0116	0.0611	CbGeAlD
Methyldopa—Lightheadedness—Metformin—polycystic ovary syndrome	0.0116	0.0455	CcSEcCtD
Methyldopa—COMT—adrenal cortex—polycystic ovary syndrome	0.0116	0.0609	CbGeAlD
Methyldopa—DDC—endocrine gland—polycystic ovary syndrome	0.011	0.0576	CbGeAlD
Methyldopa—COMT—endometrium—polycystic ovary syndrome	0.0104	0.0544	CbGeAlD
Methyldopa—Nasal congestion—Metformin—polycystic ovary syndrome	0.0103	0.0405	CcSEcCtD
Methyldopa—COMT—uterus—polycystic ovary syndrome	0.00954	0.0501	CbGeAlD
Methyldopa—COMT—pituitary gland—polycystic ovary syndrome	0.00937	0.0492	CbGeAlD
Methyldopa—COMT—adipose tissue—polycystic ovary syndrome	0.00933	0.049	CbGeAlD
Methyldopa—SLC15A1—vagina—polycystic ovary syndrome	0.00872	0.0458	CbGeAlD
Methyldopa—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00869	0.034	CcSEcCtD
Methyldopa—Breast disorder—Metformin—polycystic ovary syndrome	0.0085	0.0333	CcSEcCtD
Methyldopa—COMT—adrenal gland—polycystic ovary syndrome	0.00837	0.0439	CbGeAlD
Methyldopa—Abdominal distension—Metformin—polycystic ovary syndrome	0.00819	0.0321	CcSEcCtD
Methyldopa—SLC15A1—endocrine gland—polycystic ovary syndrome	0.00816	0.0428	CbGeAlD
Methyldopa—Pancreatitis—Metformin—polycystic ovary syndrome	0.00798	0.0312	CcSEcCtD
Methyldopa—Angina pectoris—Metformin—polycystic ovary syndrome	0.00792	0.031	CcSEcCtD
Methyldopa—COMT—female gonad—polycystic ovary syndrome	0.0078	0.041	CbGeAlD
Methyldopa—COMT—vagina—polycystic ovary syndrome	0.00775	0.0407	CbGeAlD
Methyldopa—COMT—endocrine gland—polycystic ovary syndrome	0.00726	0.0381	CbGeAlD
Methyldopa—Infestation NOS—Metformin—polycystic ovary syndrome	0.00725	0.0284	CcSEcCtD
Methyldopa—Infestation—Metformin—polycystic ovary syndrome	0.00725	0.0284	CcSEcCtD
Methyldopa—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00686	0.0269	CcSEcCtD
Methyldopa—Bradycardia—Metformin—polycystic ovary syndrome	0.00663	0.026	CcSEcCtD
Methyldopa—Hepatitis—Metformin—polycystic ovary syndrome	0.00651	0.0255	CcSEcCtD
Methyldopa—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.0064	0.0251	CcSEcCtD
Methyldopa—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00604	0.0237	CcSEcCtD
Methyldopa—Angiopathy—Metformin—polycystic ovary syndrome	0.00591	0.0231	CcSEcCtD
Methyldopa—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00587	0.023	CcSEcCtD
Methyldopa—Flatulence—Metformin—polycystic ovary syndrome	0.00558	0.0219	CcSEcCtD
Methyldopa—ADRA2A—endometrium—polycystic ovary syndrome	0.00527	0.0277	CbGeAlD
Methyldopa—ADRA2A—uterus—polycystic ovary syndrome	0.00486	0.0255	CbGeAlD
Methyldopa—Myalgia—Metformin—polycystic ovary syndrome	0.00483	0.0189	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00479	0.0188	CcSEcCtD
Methyldopa—ADRA2A—pituitary gland—polycystic ovary syndrome	0.00477	0.025	CbGeAlD
Methyldopa—ADRA2A—adipose tissue—polycystic ovary syndrome	0.00475	0.0249	CbGeAlD
Methyldopa—Oedema—Metformin—polycystic ovary syndrome	0.00463	0.0181	CcSEcCtD
Methyldopa—Infection—Metformin—polycystic ovary syndrome	0.0046	0.018	CcSEcCtD
Methyldopa—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00454	0.0178	CcSEcCtD
Methyldopa—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00453	0.0177	CcSEcCtD
Methyldopa—Skin disorder—Metformin—polycystic ovary syndrome	0.00449	0.0176	CcSEcCtD
Methyldopa—ADRA2A—adrenal gland—polycystic ovary syndrome	0.00426	0.0224	CbGeAlD
Methyldopa—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00421	0.0165	CcSEcCtD
Methyldopa—Paraesthesia—Metformin—polycystic ovary syndrome	0.00415	0.0163	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00399	0.0156	CcSEcCtD
Methyldopa—ADRA2A—female gonad—polycystic ovary syndrome	0.00397	0.0209	CbGeAlD
Methyldopa—Constipation—Metformin—polycystic ovary syndrome	0.00396	0.0155	CcSEcCtD
Methyldopa—ADRA2A—vagina—polycystic ovary syndrome	0.00395	0.0207	CbGeAlD
Methyldopa—ADRA2A—endocrine gland—polycystic ovary syndrome	0.0037	0.0194	CbGeAlD
Methyldopa—Droxidopa—ADRA1D—polycystic ovary syndrome	0.00338	0.0568	CrCbGaD
Methyldopa—Asthenia—Metformin—polycystic ovary syndrome	0.00332	0.013	CcSEcCtD
Methyldopa—Diarrhoea—Metformin—polycystic ovary syndrome	0.00316	0.0124	CcSEcCtD
Methyldopa—Dizziness—Metformin—polycystic ovary syndrome	0.00306	0.012	CcSEcCtD
Methyldopa—Droxidopa—ADRB3—polycystic ovary syndrome	0.00304	0.051	CrCbGaD
Methyldopa—Vomiting—Metformin—polycystic ovary syndrome	0.00294	0.0115	CcSEcCtD
Methyldopa—Rash—Metformin—polycystic ovary syndrome	0.00292	0.0114	CcSEcCtD
Methyldopa—Dermatitis—Metformin—polycystic ovary syndrome	0.00291	0.0114	CcSEcCtD
Methyldopa—Headache—Metformin—polycystic ovary syndrome	0.0029	0.0114	CcSEcCtD
Methyldopa—Droxidopa—ADRA1B—polycystic ovary syndrome	0.00289	0.0485	CrCbGaD
Methyldopa—Norepinephrine—ADRA1D—polycystic ovary syndrome	0.00285	0.0478	CrCbGaD
Methyldopa—Isoprenaline—ADRB3—polycystic ovary syndrome	0.00276	0.0464	CrCbGaD
Methyldopa—Levonordefrin—ADRA1A—polycystic ovary syndrome	0.00276	0.0463	CrCbGaD
Methyldopa—Nausea—Metformin—polycystic ovary syndrome	0.00275	0.0108	CcSEcCtD
Methyldopa—Epinephrine—ADRA1D—polycystic ovary syndrome	0.00258	0.0434	CrCbGaD
Methyldopa—Norepinephrine—ADRB3—polycystic ovary syndrome	0.00256	0.0429	CrCbGaD
Methyldopa—Isoetarine—ADRB2—polycystic ovary syndrome	0.00253	0.0425	CrCbGaD
Methyldopa—Norepinephrine—ADRA1B—polycystic ovary syndrome	0.00243	0.0408	CrCbGaD
Methyldopa—Epinephrine—ADRB3—polycystic ovary syndrome	0.00232	0.039	CrCbGaD
Methyldopa—Epinephrine—ADRA1B—polycystic ovary syndrome	0.0022	0.037	CrCbGaD
Methyldopa—Mesalazine—PPARG—polycystic ovary syndrome	0.00195	0.0327	CrCbGaD
Methyldopa—Droxidopa—ADRA1A—polycystic ovary syndrome	0.00194	0.0326	CrCbGaD
Methyldopa—Norepinephrine—ADRA1A—polycystic ovary syndrome	0.00163	0.0275	CrCbGaD
Methyldopa—Epinephrine—ADRA1A—polycystic ovary syndrome	0.00148	0.0249	CrCbGaD
Methyldopa—COMT—Metabolism—NMNAT3—polycystic ovary syndrome	0.00116	0.00235	CbGpPWpGaD
Methyldopa—Droxidopa—ADRB2—polycystic ovary syndrome	0.00116	0.0194	CrCbGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRA1B—polycystic ovary syndrome	0.00115	0.00233	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.00114	0.0023	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.00112	0.00226	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.00112	0.00226	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ISYNA1—polycystic ovary syndrome	0.00111	0.00225	CbGpPWpGaD
Methyldopa—ADRA2A—Regulation of insulin secretion—GNAS—polycystic ovary syndrome	0.00111	0.00224	CbGpPWpGaD
Methyldopa—COMT—Metabolism—LPCAT2—polycystic ovary syndrome	0.00106	0.00215	CbGpPWpGaD
Methyldopa—COMT—Metabolism—SUOX—polycystic ovary syndrome	0.00106	0.00215	CbGpPWpGaD
Methyldopa—Isoprenaline—ADRB2—polycystic ovary syndrome	0.00105	0.0176	CrCbGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.00104	0.00211	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—NPB—polycystic ovary syndrome	0.00102	0.00206	CbGpPWpGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.00102	0.00206	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.00101	0.00205	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.000993	0.00201	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ISYNA1—polycystic ovary syndrome	0.000988	0.002	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.000986	0.00199	CbGpPWpGaD
Methyldopa—COMT—Biological oxidations—POMC—polycystic ovary syndrome	0.000985	0.00199	CbGpPWpGaD
Methyldopa—Norepinephrine—ADRB2—polycystic ovary syndrome	0.000972	0.0163	CrCbGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.000954	0.00193	CbGpPWpGaD
Methyldopa—DDC—Metabolism—TEAD2—polycystic ovary syndrome	0.000946	0.00191	CbGpPWpGaD
Methyldopa—DDC—Metabolism—AKR1C2—polycystic ovary syndrome	0.000946	0.00191	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—GP1BB—polycystic ovary syndrome	0.000911	0.00184	CbGpPWpGaD
Methyldopa—Isoprenaline—CYP1A1—polycystic ovary syndrome	0.0009	0.0151	CrCbGaD
Methyldopa—DDC—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.000895	0.00181	CbGpPWpGaD
Methyldopa—Epinephrine—ADRB2—polycystic ovary syndrome	0.000882	0.0148	CrCbGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.000872	0.00176	CbGpPWpGaD
Methyldopa—ADRA2A—Integration of energy metabolism—GNAS—polycystic ovary syndrome	0.00087	0.00176	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00085	0.00172	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00085	0.00172	CbGpPWpGaD
Methyldopa—COMT—Metabolism—AKR1C2—polycystic ovary syndrome	0.00084	0.0017	CbGpPWpGaD
Methyldopa—COMT—Metabolism—TEAD2—polycystic ovary syndrome	0.00084	0.0017	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.00084	0.0017	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.000817	0.00165	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—MTNR1B—polycystic ovary syndrome	0.000799	0.00162	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.000795	0.00161	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PNPLA2—polycystic ovary syndrome	0.000793	0.0016	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.000772	0.00156	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000754	0.00152	CbGpPWpGaD
Methyldopa—DDC—Metabolism—SRD5A1—polycystic ovary syndrome	0.000752	0.00152	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.000751	0.00152	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.000747	0.00151	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.000742	0.0015	CbGpPWpGaD
Methyldopa—ADRA2A—Regulation of insulin secretion—INS—polycystic ovary syndrome	0.000741	0.0015	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.000719	0.00145	CbGpPWpGaD
Methyldopa—DDC—Metabolism—STAR—polycystic ovary syndrome	0.000717	0.00145	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.000711	0.00144	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PNPLA2—polycystic ovary syndrome	0.000704	0.00142	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.000695	0.0014	CbGpPWpGaD
Methyldopa—COMT—Metabolism—SRD5A1—polycystic ovary syndrome	0.000668	0.00135	CbGpPWpGaD
Methyldopa—DDC—Metabolism—HMMR—polycystic ovary syndrome	0.000639	0.00129	CbGpPWpGaD
Methyldopa—COMT—Metabolism—STAR—polycystic ovary syndrome	0.000637	0.00129	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.000635	0.00128	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.000622	0.00126	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—PDE3B—polycystic ovary syndrome	0.000611	0.00123	CbGpPWpGaD
Methyldopa—DDC—Metabolism—HSD3B1—polycystic ovary syndrome	0.00061	0.00123	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000609	0.00123	CbGpPWpGaD
Methyldopa—ADRA2A—Integration of energy metabolism—INS—polycystic ovary syndrome	0.000582	0.00118	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000576	0.00116	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.000569	0.00115	CbGpPWpGaD
Methyldopa—COMT—Metabolism—HMMR—polycystic ovary syndrome	0.000568	0.00115	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000566	0.00114	CbGpPWpGaD
Methyldopa—DDC—Metabolism—LHB—polycystic ovary syndrome	0.000556	0.00112	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000548	0.00111	CbGpPWpGaD
Methyldopa—DDC—Metabolism—HSD3B2—polycystic ovary syndrome	0.000544	0.0011	CbGpPWpGaD
Methyldopa—COMT—Metabolism—HSD3B1—polycystic ovary syndrome	0.000541	0.00109	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000541	0.00109	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000529	0.00107	CbGpPWpGaD
Methyldopa—DDC—Metabolism—AKR1C1—polycystic ovary syndrome	0.000526	0.00106	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—RACGAP1—polycystic ovary syndrome	0.000523	0.00106	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000523	0.00106	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000521	0.00105	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000521	0.00105	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000517	0.00105	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00051	0.00103	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00051	0.00103	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000507	0.00103	CbGpPWpGaD
Methyldopa—COMT—Metabolism—LHB—polycystic ovary syndrome	0.000494	0.000998	CbGpPWpGaD
Methyldopa—DDC—Metabolism—SULT2A1—polycystic ovary syndrome	0.000484	0.000979	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000484	0.000978	CbGpPWpGaD
Methyldopa—COMT—Metabolism—HSD3B2—polycystic ovary syndrome	0.000483	0.000975	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00048	0.000971	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00048	0.000971	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000473	0.000955	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000469	0.000948	CbGpPWpGaD
Methyldopa—DDC—Metabolism—RRM2—polycystic ovary syndrome	0.000469	0.000948	CbGpPWpGaD
Methyldopa—COMT—Metabolism—AKR1C1—polycystic ovary syndrome	0.000467	0.000945	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NMNAT3—polycystic ovary syndrome	0.000462	0.000933	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.000453	0.000916	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.000453	0.000916	CbGpPWpGaD
Methyldopa—DDC—Metabolism—YAP1—polycystic ovary syndrome	0.000452	0.000914	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000449	0.000908	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000436	0.000882	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000436	0.000882	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000436	0.000882	CbGpPWpGaD
Methyldopa—DDC—Metabolism—NAMPT—polycystic ovary syndrome	0.000435	0.000878	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000434	0.000878	CbGpPWpGaD
Methyldopa—COMT—Metabolism—SULT2A1—polycystic ovary syndrome	0.00043	0.000869	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CYP11A1—polycystic ovary syndrome	0.000429	0.000867	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000426	0.00086	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000424	0.000858	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—LPCAT2—polycystic ovary syndrome	0.000422	0.000854	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—SUOX—polycystic ovary syndrome	0.000422	0.000854	CbGpPWpGaD
Methyldopa—COMT—Metabolism—RRM2—polycystic ovary syndrome	0.000417	0.000842	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000408	0.000825	CbGpPWpGaD
Methyldopa—DDC—Metabolism—AKR1C3—polycystic ovary syndrome	0.000405	0.000819	CbGpPWpGaD
Methyldopa—COMT—Metabolism—YAP1—polycystic ovary syndrome	0.000402	0.000812	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CYP17A1—polycystic ovary syndrome	0.000399	0.000806	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000396	0.000801	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ISYNA1—polycystic ovary syndrome	0.000393	0.000794	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000388	0.000785	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000386	0.00078	CbGpPWpGaD
Methyldopa—COMT—Metabolism—NAMPT—polycystic ovary syndrome	0.000386	0.00078	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000385	0.000779	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CYP11A1—polycystic ovary syndrome	0.000381	0.00077	CbGpPWpGaD
Methyldopa—COMT—Metabolism—AKR1C3—polycystic ovary syndrome	0.00036	0.000727	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000357	0.000722	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CYP17A1—polycystic ovary syndrome	0.000354	0.000716	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000353	0.000714	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000352	0.000711	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000351	0.000708	CbGpPWpGaD
Methyldopa—DDC—Metabolism—TH—polycystic ovary syndrome	0.000345	0.000698	CbGpPWpGaD
Methyldopa—DDC—Metabolism—SLC2A4—polycystic ovary syndrome	0.000336	0.000679	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—AKR1C2—polycystic ovary syndrome	0.000334	0.000675	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—TEAD2—polycystic ovary syndrome	0.000334	0.000675	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000322	0.00065	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—PLAT—polycystic ovary syndrome	0.00032	0.000646	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000319	0.000645	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CYP19A1—polycystic ovary syndrome	0.000316	0.000638	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00031	0.000626	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NPB—polycystic ovary syndrome	0.000309	0.000624	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	0.000308	0.000623	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	0.000308	0.000622	CbGpPWpGaD
Methyldopa—COMT—Metabolism—TH—polycystic ovary syndrome	0.000307	0.000619	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000306	0.000618	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000305	0.000616	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000299	0.000604	CbGpPWpGaD
Methyldopa—COMT—Metabolism—SLC2A4—polycystic ovary syndrome	0.000298	0.000603	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000296	0.000598	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	0.000293	0.000591	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000292	0.00059	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000287	0.000579	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GNAS—polycystic ovary syndrome	0.000282	0.00057	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000281	0.000568	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CYP19A1—polycystic ovary syndrome	0.00028	0.000567	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PNPLA2—polycystic ovary syndrome	0.00028	0.000566	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000279	0.000564	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000278	0.000561	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000274	0.000554	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000273	0.000553	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000271	0.000549	CbGpPWpGaD
Methyldopa—DDC—Metabolism—NCOR1—polycystic ovary syndrome	0.000268	0.000543	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—SRD5A1—polycystic ovary syndrome	0.000265	0.000536	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00026	0.000526	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000258	0.000521	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000258	0.000521	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CYP1A1—polycystic ovary syndrome	0.000254	0.000514	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—STAR—polycystic ovary syndrome	0.000253	0.000511	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GNAS—polycystic ovary syndrome	0.00025	0.000506	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000248	0.000502	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—GNAS—polycystic ovary syndrome	0.000245	0.000496	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000243	0.00049	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000241	0.000487	CbGpPWpGaD
Methyldopa—COMT—Metabolism—NCOR1—polycystic ovary syndrome	0.000238	0.000482	CbGpPWpGaD
Methyldopa—DDC—Metabolism—MTHFR—polycystic ovary syndrome	0.000237	0.000479	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000234	0.000473	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000228	0.00046	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CYP1A1—polycystic ovary syndrome	0.000226	0.000457	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—HMMR—polycystic ovary syndrome	0.000226	0.000456	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000222	0.000448	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—HSD3B1—polycystic ovary syndrome	0.000215	0.000435	CbGpPWpGaD
Methyldopa—COMT—Metabolism—MTHFR—polycystic ovary syndrome	0.000211	0.000426	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000207	0.000419	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000202	0.000408	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	0.000201	0.000407	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—LHB—polycystic ovary syndrome	0.000196	0.000397	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PPARG—polycystic ovary syndrome	0.000192	0.000389	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—HSD3B2—polycystic ovary syndrome	0.000192	0.000388	CbGpPWpGaD
Methyldopa—DDC—Metabolism—POMC—polycystic ovary syndrome	0.00019	0.000383	CbGpPWpGaD
Methyldopa—DDC—Metabolism—INS—polycystic ovary syndrome	0.000189	0.000381	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000189	0.000381	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—AKR1C1—polycystic ovary syndrome	0.000186	0.000375	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000185	0.000373	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000183	0.000371	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000177	0.000358	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000173	0.000349	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—SULT2A1—polycystic ovary syndrome	0.000171	0.000345	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PPARG—polycystic ovary syndrome	0.000171	0.000345	CbGpPWpGaD
Methyldopa—COMT—Metabolism—POMC—polycystic ovary syndrome	0.000168	0.00034	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—FST—polycystic ovary syndrome	0.000168	0.00034	CbGpPWpGaD
Methyldopa—COMT—Metabolism—INS—polycystic ovary syndrome	0.000168	0.000339	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000167	0.000338	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000166	0.000336	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—RRM2—polycystic ovary syndrome	0.000166	0.000335	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000164	0.000332	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00016	0.000324	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—YAP1—polycystic ovary syndrome	0.00016	0.000323	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IGF1—polycystic ovary syndrome	0.000159	0.000321	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—AKT2—polycystic ovary syndrome	0.000159	0.000321	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000155	0.000314	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000155	0.000313	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000154	0.000311	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NAMPT—polycystic ovary syndrome	0.000153	0.00031	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000152	0.000307	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CYP11A1—polycystic ovary syndrome	0.000151	0.000306	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000151	0.000305	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000147	0.000296	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000144	0.000291	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—AKR1C3—polycystic ovary syndrome	0.000143	0.000289	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000143	0.000289	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CYP17A1—polycystic ovary syndrome	0.000141	0.000285	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000141	0.000284	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000133	0.00027	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000132	0.000266	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000126	0.000254	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—TH—polycystic ovary syndrome	0.000122	0.000246	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00012	0.000242	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—SLC2A4—polycystic ovary syndrome	0.000118	0.000239	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000118	0.000238	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000117	0.000236	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CYP19A1—polycystic ovary syndrome	0.000111	0.000225	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000108	0.000219	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000108	0.000219	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000104	0.000211	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—VEGFA—polycystic ovary syndrome	0.000104	0.00021	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000103	0.000209	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000101	0.000204	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.0001	0.000203	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GNAS—polycystic ovary syndrome	9.94e-05	0.000201	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NGFR—polycystic ovary syndrome	9.54e-05	0.000193	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—POMC—polycystic ovary syndrome	9.48e-05	0.000192	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NCOR1—polycystic ovary syndrome	9.47e-05	0.000191	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PRL—polycystic ovary syndrome	9.45e-05	0.000191	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.11e-05	0.000184	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CYP1A1—polycystic ovary syndrome	8.98e-05	0.000181	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	8.97e-05	0.000181	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—MTHFR—polycystic ovary syndrome	8.37e-05	0.000169	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	8.32e-05	0.000168	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.92e-05	0.00016	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	7.78e-05	0.000157	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	6.79e-05	0.000137	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	6.7e-05	0.000135	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	6.66e-05	0.000135	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—INS—polycystic ovary syndrome	6.66e-05	0.000135	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	6.52e-05	0.000132	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	5.81e-05	0.000117	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	5.6e-05	0.000113	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	5.57e-05	0.000113	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	5.39e-05	0.000109	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	5.38e-05	0.000109	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.11e-05	0.000103	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	4.12e-05	8.32e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.52e-05	7.11e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	2.43e-05	4.92e-05	CbGpPWpGaD
